Search
for
Sort by
Research 31–60 of 1000+
- Immunosuppressive treatment for proliferative lupus nephritis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Introduction to Transplantology
- Dermatolojik Problemler ve COVID-19
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Botulinum toxin type A for the management of hidradenitis suppurativa.
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- An Update on Medical Treatment Options for Hidradenitis Suppurativa
- Poster Presentations
- Oral Lichen Planus
- Immune therapies for alopecia areata: evidence and new perspectives
- New Modalities in the Treatment of Refractory Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Platelet-Rich Concentrates in the Management of Lichen Planus—A Comprehensive Review
- VITILIGO: WHAT’S OLD, WHAT’S NEW?
- Lichen planus – A refractory autoimmune disorder
- Increased blood levels of NKG2D+CD4+ T cells in patients with alopecia areata
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata